Advertisement
U.S. markets open in 3 hours 45 minutes

Xtant Medical Holdings, Inc. (XTNT)

NYSE American - NYSE American Delayed Price. Currency in USD
1.1100+0.0500 (+4.72%)
At close: 04:00PM EDT
1.1100 0.00 (0.00%)
After hours: 07:26PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.0600
Open1.0500
Bid0.0000 x 1200
Ask1.3000 x 1800
Day's Range1.0500 - 1.1500
52 Week Range0.5600 - 1.4500
Volume349,757
Avg. Volume113,514
Market Cap144.422M
Beta (5Y Monthly)0.20
PE Ratio (TTM)55.50
EPS (TTM)0.0200
Earnings DateApr 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.93
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for XTNT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Xtant Medical Holdings, Inc.
    GMED: Lowering target price to $41.00GLOBUS MEDICAL INC - A has an Investment Rating of SELL; a target price of $41.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • GlobeNewswire

    Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024

    BELGRADE, Mont., March 21, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2023, before the open of the financial markets on Monday, April 1, 2024. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host

  • GlobeNewswire

    Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial

    BELGRADE, Mont., March 07, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company’s revolving credit agreement with MidCap Financial Trust (“MidCap”) was amended to increase the commitment from $8.0 million to $17.0 million. The Company’s term loan was also amended to provide for an additional $10.0 million tranche, to be made available f

  • GlobeNewswire

    Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference

    BELGRADE, Mont., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the TD Cowen 44th Annual Healthcare Conference, to be held on Monday, March 4, 2024 at 12:50 p.m. Eastern Time in Boston. A live webcast of the presentation will be available on the Investors section of the Company’s